Detalles de la búsqueda
1.
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 23(10): 1287-1296, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36096156
2.
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
Cancer Immunol Immunother
; 68(9): 1547-1559, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31482307
3.
Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment.
Pharmacol Res
; 117: 406-415, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28089942
4.
Molecular and clinical features of second-generation anaplastic lymphoma kinase inhibitors: ceritinib.
Future Oncol
; 13(29): 2629-2644, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28891712
5.
Molecular features and clinical outcome of lung malignancies in very young people.
Future Oncol
; 11(8): 1211-21, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25832878
6.
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.
Oncologist
; 19(4): 344-5, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24674875
7.
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.
Clin Cancer Res
; 30(6): 1093-1103, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37906083
8.
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer."
Breast
; 73: 103672, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244459
9.
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program.
Lung Cancer
; 187: 107444, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157806
10.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
11.
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review.
Curr Oncol
; 30(3): 3494-3499, 2023 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36975478
12.
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study.
Lung Cancer
; 176: 98-102, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36630822
13.
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group.
Crit Rev Oncol Hematol
; 190: 104108, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633350
14.
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials.
Breast
; 69: 258-264, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898259
15.
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis.
Semin Oncol
; 50(6): 140-143, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38065801
16.
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis.
Semin Oncol
; 50(1-2): 34-39, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967333
17.
The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.
Clin Lung Cancer
; 23(2): 108-115, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952792
18.
Sex and cancer immunotherapy: Current understanding and challenges.
Cancer Cell
; 40(7): 695-700, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35750053
19.
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
Front Oncol
; 12: 980765, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36033444
20.
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy.
Eur J Cancer
; 172: 332-339, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820244